Tornier, an orthopedic extremity device manufacturer, has filed for a $205 million IPO, according to a filing with the U.S. Securities and Exchange Commission and industry reports.
Tornier, a Netherlands-based company with U.S. headquarters in Edina, Minn., offers a broad range of joint replacement products including hips, knees, shoulders, ankles and other extremity prostheses.
Tornier has proposed its NASDAQ symbol as TRNX.
Read the U.S. Securities and Exchange Commission filing for Tornier.
Tornier, a Netherlands-based company with U.S. headquarters in Edina, Minn., offers a broad range of joint replacement products including hips, knees, shoulders, ankles and other extremity prostheses.
Tornier has proposed its NASDAQ symbol as TRNX.
Read the U.S. Securities and Exchange Commission filing for Tornier.